๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Puducherry
Clinical trial register · India

Clinical Trials in Puducherry

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1125 matching records held by the registry are in this view. Synced 22 Sep 2026, 03:16 UTC
1125
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
221
Lead sponsors
across recruiting studies
Top sites
New Delhi 334 Mumbai 259 Hyderabad 238 Bangalore 194 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca2 Population Health Research Institute2 Celgene2 Bristol-Myers Squibb2 Takeda1
Site location
New Delhi334 Mumbai259 Hyderabad238 Bangalore194 Pune189
All 273 locations
Target enrolment
to
16 of 1125 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
Peripheral Vascular Disease as a Clinical Trigger for Opportunistic Lung Cancer Screening Referral: An Implementation Study
NCT07598279Lung Cancer, Peripheral Vascular Diseases, Ankle Brachial Index, Low Dose Computed Tomography
International Agency for Research on Cancer
Not applicable
355
Puducherry
2026-06-01
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
NCT07221149Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma
Bristol-Myers Squibb
Phase 2/3
690
Nashik, Mumbai, Delhi, Puducherry, Pune
2026-03-13
Not yet open
Affordable Made-in-India Microspheres for Liver Cancer Therapy
NCT07436988Hepatecellular Carcinoma
Post Graduate Institute of Medical Education and Research, Chandigarh
Phase 1
18
Chandigarh, Mumbai, Bhubaneswar, Puducherry, Delhi
2026-02-15
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357Untreated, Unresectable, or Metastatic Colorectal Cancer
Bristol-Myers Squibb
Phase 2/3
990
Nashik, Thiruvananthapuram, Mumbai, Delhi, Puducherry, Pune
2025-12-31
Recruiting
Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (โ‰ฅ18 Years) Primary IgA Nephropathy?
NCT06676384IgA Nephropathy, Renal Insufficiency, Chronic, IgA Vasculitis, IGA Glomerulonephritis
Christian Medical College, Vellore, India
Phase 4
585
Nadiฤd, Mysuru, Udupi, Mumbai, Delhi, Bhubaneswar, Puducherry, Chennai
2025-02-15
Recruiting
A Study of Brentuximab Vedotin With Doxorubicin, Vinblastine and Dacarbazine in Adults With Hodgkin Lymphoma in India
NCT06831370Hodgkin Lymphoma
Takeda
Phase 4
124
Vijayawada, Guwahati, Surat, Bangalore, Puducherry, Nashik, Navi Mumbai, Pune
2024-08-28
Active, closed
SODium BICarbonate for Metabolic Acidosis in the ICU
NCT05697770Metabolic Acidosis, Shock
Australian and New Zealand Intensive Care Research Centre
Phase 3
500
Puducherry, Ludhiana
2023-04-26
Active, closed
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Carcinoma
CanariaBio Inc.
Phase 2
88
Visakhapatnam, Vadodara, Belagavi, Kochi, Trivandrum, Puducherry, Jaipur, Chennai
2023-02-07
Active, closed
Phase III, Open-label, First-line Study of Dato-DXd in Combination With Durvalumab and Carboplatin for Advanced NSCLC Without Actionable Genomic Alterations
NCT05687266NSCLC
AstraZeneca
Phase 3
1,350
Calicut, Delhi, Jaipur, Kolkata, Madurai, Puducherry
2022-12-29
Recruiting
Pharmacogenomic Association Study in Indian Children With Acute Lymphoblastic Leukemia
NCT05512169ALL, Childhood, Pediatric Cancer, Toxicity, Drug, Adverse Drug Event
University of Geneva, Switzerland
Observational
556
New Delhi, Puducherry
2022-12-01
Recruiting
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT05519085Relapsed or Refractory Multiple Myeloma
Celgene
Phase 3
810
Ahmedabad, Gurugram, Belagavi, Mumbai, Madurai, Varanasi, Ludhiana, Puducherry
2022-09-20
Recruiting
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
NCT05268289Lupus Nephritis
Novartis Pharmaceuticals
Phase 2
240
Ahmedabad, Kozhikode, New Delhi, Vellore, Hyderabad, Lucknow, Puducherry
2022-08-10
Active, closed
Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
NCT04975997Multiple Myeloma
Celgene
Phase 3
939
Hyderabad, Bangalore, Ernฤkulam, Mumbai, Kolkata, Puducherry
2022-06-23
Active, closed
A Study of Dato-DXd Versus Investigator's Choice Chemotherapy in Patients With Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer, Who Are Not Candidates for PD-1/PD-L1 Inhibitor Therapy (TROPION-Breast02)
NCT05374512Breast Cancer
AstraZeneca
Phase 3
644
Bangalore, Jaipur, Kolkata, Nagpur, Nashik, New Delhi, Puducherry, Vadodara
2022-05-16
Recruiting
HIP Fracture Accelerated Surgical TreaTment And Care tracK 2 Trial
NCT04743765Hip Fractures, Myocardial Injury
Population Health Research Institute
Not applicable
1,100
Bangalore, Alappuzha, Trivandrum, New Delhi, Puducherry
2021-11-22
Recruiting
Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress
NCT03968393Stroke, Atrial Fibrillation
Population Health Research Institute
Phase 4
2,270
North Guwฤhฤti, Ahmedabad, Bangalore, Alappuzha, Thrissur, Puducherry, Pune, Thiruvananthapuram
2019-06-14
Rows per page Showing 1–16 of 16
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 22 September 2026. https://priyalifescience.com/clinical-trials-india/city/puducherry

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.